Amedeo Smart

Free Medical Literature Service

 

Amedeo

Malignant Lymphoma
  Free Subscription

Articles published in
N Engl J Med
    April 2024
  1. HU Y, Zhang M, Yang T, Mo Z, et al
    Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
    N Engl J Med. 2024;390:1467-1480.
    >> Share

    March 2024
  2. VIPLER B
    "What's Lymphoma?" - Risks Posed by Immediate Release of Test Results to Patients.
    N Engl J Med. 2024;390:1064-1066.
    >> Share

    December 2023
  3. CHENG JW, Li JH
    Intravascular Large B-Cell Lymphoma.
    N Engl J Med. 2023;389:2188.
    >> Share

    September 2023
  4. WESTIN JR, To C, Locke FL
    Axicabtagene Ciloleucel in Large B-Cell Lymphoma. Reply.
    N Engl J Med. 2023;389:1152-1153.
    >> Share

  5. ZHAO WL, Wu DP, Hu Y
    Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
    N Engl J Med. 2023;389:1152-1153.
    >> Share

    July 2023
  6. HOFACKER SA, Schmidt EP
    Case 11-2023: A Man with Mantle-Cell Lymphoma and Hypoxemia. Reply.
    N Engl J Med. 2023;389:95.
    >> Share

  7. GUPTA A
    Case 11-2023: A Man with Mantle-Cell Lymphoma and Hypoxemia.
    N Engl J Med. 2023;389:94-95.
    >> Share

    June 2023
  8. WESTIN JR, Oluwole OO, Kersten MJ, Miklos DB, et al
    Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
    N Engl J Med. 2023 Jun 5. doi: 10.1056/NEJMoa2301665.
    >> Share

    May 2023
  9. BROWN JR, Cohen A, Shadman M
    Zanubrutinib in Chronic Lymphocytic Leukemia. Reply.
    N Engl J Med. 2023;388:1720-1721.
    >> Share

  10. LIANG Y, Gale RP
    Zanubrutinib in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2023;388:1720.
    >> Share

  11. BYRD JC, Rothbaum W
    Zanubrutinib in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2023;388:1719-1720.
    >> Share

    April 2023
  12. SCHMIDT EP, Shepard JO, Liu L
    Case 11-2023: A 67-Year-Old Man with Mantle-Cell Lymphoma and Hypoxemia.
    N Engl J Med. 2023;388:1416-1423.
    >> Share

    December 2022
  13. DICKINSON MJ, Carlo-Stella C, Morschhauser F, Bachy E, et al
    Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
    N Engl J Med. 2022;387:2220-2231.
    >> Share

  14. BARTLETT NL
    Bispecific Antibodies in Lymphoma - Another Win for T Cells.
    N Engl J Med. 2022;387:2285-2286.
    >> Share

    November 2022
  15. ROSCHEWSKI M, Bollard CM
    Are We Too Reliant on Radiation Therapy for Children with Hodgkin's Lymphoma?
    N Engl J Med. 2022;387:1710-1712.
    >> Share

  16. CASTELLINO SM, Pei Q, Parsons SK, Hodgson D, et al
    Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.
    N Engl J Med. 2022;387:1649-1660.
    >> Share

    October 2022
  17. ANSELL SM, Radford J, Straus DJ
    Brentuximab Vedotin in Advanced Hodgkin's Lymphoma. Reply.
    N Engl J Med. 2022;387:1527-1528.
    >> Share

  18. HASLAM A, Prasad V
    Brentuximab Vedotin in Advanced Hodgkin's Lymphoma.
    N Engl J Med. 2022;387:1527.
    >> Share

    September 2022
  19. WANG ML, Le Gouill S, Dreyling M
    Treatment of Mantle-Cell Lymphoma. Reply.
    N Engl J Med. 2022;387:1148.
    >> Share

  20. ESKAZAN AE
    Treatment of Mantle-Cell Lymphoma.
    N Engl J Med. 2022;387:1147-1148.
    >> Share

  21. FERHANOGLU B, Birtas Atesoglu E, Ozbalak M
    Treatment of Mantle-Cell Lymphoma.
    N Engl J Med. 2022;387:1147.
    >> Share

  22. CLIFF ERS, Dickinson M
    Treatment of Mantle-Cell Lymphoma.
    N Engl J Med. 2022;387:1146-1147.
    >> Share

  23. ROSCHEWSKI M, Staudt LM, Wilson WH
    Burkitt's Lymphoma.
    N Engl J Med. 2022;387:1111-1122.
    >> Share

  24. ARMITAGE JO, Longo DL
    Mantle-Cell Lymphoma. Reply.
    N Engl J Med. 2022;387:1050.
    >> Share

  25. YAVORKOVSKY LL
    Mantle-Cell Lymphoma.
    N Engl J Med. 2022;387:1049.
    >> Share

    July 2022
  26. ANSELL SM, Radford J, Connors JM, Dlugosz-Danecka M, et al
    Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2022 Jul 13. doi: 10.1056/NEJMoa2206125.
    >> Share

  27. LONGO DL, Armitage JO
    A Better Treatment for Advanced-Stage Hodgkin's Lymphoma?
    N Engl J Med. 2022 Jul 13. doi: 10.1056/NEJMe2207639.
    >> Share

    June 2022
  28. ARMITAGE JO, Longo DL
    Mantle-Cell Lymphoma.
    N Engl J Med. 2022;386:2495-2506.
    >> Share

  29. WANG ML, Jurczak W, Jerkeman M, Trotman J, et al
    Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
    N Engl J Med. 2022 Jun 3. doi: 10.1056/NEJMoa2201817.
    >> Share

    May 2022
  30. BERTONI F, Rossi D, Zucca E
    Marginal-Zone Lymphomas. Reply.
    N Engl J Med. 2022;386:1962-1963.
    >> Share

  31. HENRY B, Buffet P, Bates I
    Marginal-Zone Lymphomas.
    N Engl J Med. 2022;386:1962.
    >> Share

  32. MATUCHANSKY C
    Marginal-Zone Lymphomas.
    N Engl J Med. 2022;386:1962.
    >> Share

    March 2022
  33. FORST DA, Restrepo JA, Gonzalez RG, Jones PS, et al
    Case 7-2022: A 65-Year-Old Woman with Depression, Recurrent Falls, and Inability to Care for Herself.
    N Engl J Med. 2022;386:977-986.
    >> Share

    February 2022
  34. ROSSI D, Bertoni F, Zucca E
    Marginal-Zone Lymphomas.
    N Engl J Med. 2022;386:568-581.
    >> Share

    January 2022
  35. SPANJAART AM, van der Valk FM, van Rooijen G, Brouwer MC, et al
    Confused about Confusion.
    N Engl J Med. 2022;386:80-87.
    >> Share

    December 2021
  36. TILLY H, Morschhauser F, Sehn LH, Friedberg JW, et al
    Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.
    N Engl J Med. 2021 Dec 14. doi: 10.1056/NEJMoa2115304.
    >> Share

  37. BISHOP MR, Dickinson M, Purtill D, Barba P, et al
    Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.
    N Engl J Med. 2021 Dec 14. doi: 10.1056/NEJMoa2116596.
    >> Share

  38. ROSCHEWSKI M, Longo DL, Wilson WH
    CAR T-Cell Therapy for Large B-Cell Lymphoma - Who, When, and How?
    N Engl J Med. 2021 Dec 14. doi: 10.1056/NEJMe2118899.
    >> Share

  39. LOCKE FL, Miklos DB, Jacobson CA, Perales MA, et al
    Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
    N Engl J Med. 2021 Dec 11. doi: 10.1056/NEJMoa2116133.
    >> Share

    September 2021
  40. STOKKE JL, Szymanski LJ, Bankamp B, Pratt F, et al
    MMR Vaccine-Associated Disseminated Measles in an Immunocompromised Adolescent.
    N Engl J Med. 2021;385:1246-1248.
    >> Share

  41. LYU X, Guan X
    Gingival Ulceration.
    N Engl J Med. 2021;385:e33.
    >> Share

    June 2021
  42. SEHN LH, Salles G
    Diffuse Large B-Cell Lymphoma. Reply.
    N Engl J Med. 2021;384:2262.
    >> Share

  43. LANG R, Gill MJ
    Diffuse Large B-Cell Lymphoma.
    N Engl J Med. 2021;384:2261-2262.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016